Logo7
Logo5

AppGenex Diagnostics, Inc.

AppGenex Diagnostics develops multiplexed diagnostic products for the detection of diseases caused by infectious pathogens.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Mountain View, CA, USA
  • Currency USD
  • Founded January 2011
  • Incorporation Type C-corp
  • Website appgenex.com

Company Summary

AppGenex Diagnostics, Inc. develops and provides multiplexed products for diagnosis of infectious disease. The Company’s strategic focus is on unmet diagnostic need of human diseases, such as tuberculosis (TB), affecting the developing world. Our main product is a TB Detection Panel intended as a first-line test for use in clinics with high TB patient volumes. The panel is slated to be launched in India in 2018.

Team

  • Ee0c272e b1af 48da 9cd6 5e614de0abeb
    CEO and Co-Founder

    Former Director of Virology at PPD Discovery, Inc. and former CEO and Co-Founder at Avatar Vaccines, Inc.

  • Default avatar
    Imran Khan
    Co-Founder

    Associate Professor, Dept. of Pathology and Laboratory Medicine and Associate Director of the Clinical Proteomics Core, UC Davis

  • Default avatar
    Paul A. Luciw
    Co-Founder

    Professor, Dept. of Pathology and Laboratory Medicine and Director of the Clinical Proteomics Core, UC Davis